Report Feature
The future of the global coagulation testing market looks promising with opportunities in activated clotting time (ACT), thrombin time (TT), partial thromboplastin time (PTT), activated partial thromboplastin time (aPTT), and prothrombin time (PT) applications. The global coagulation testing market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are rising prevalence of blood disorders & cardiovascular diseases, increasing geriatric population, and advancement in technologies, such as easy-to-use and faster devices with advanced sensor technology.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global coagulation testing market report, please download the report brochure.
In this market, consumables is the largest product of coagulation testing, whereas hospitals is the largest end user. Growth in various segments of the coagulation testing market are given below:
The study includes trends and forecast for the global coagulation testing market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Instruments
Consumables
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Optical Technology
Mechanical Technology
Electrochemical Technology
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Activated Clotting Time
Thrombin Time
Partial Thromboplastin Time
Activated Partial Thromboplastin Time
Prothrombin Time
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
German
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the coagulation testing companies profiled in this report include Alere, Nihon Kohden, Roche, Sysmex, Thermo Fisher Scientific, Diagnostica Stago, Helena Laboratories, Abbott Laboratories, Medtronic, and Micropoint Biosciences.
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to increasing research and development activities related to analyzers and rising technological advancements.
Within this market, hospitals will remain the largest end user segment over the forecast period due to increasing demand for comprehensive medical care and new innovation in therapeutic techniques.
Asia Pacific is expected to witness the highest growth over the forecast period due to increasing cases of blood disorders, growing geriatric population, and rising healthcare spending in the region.
|
Features of the Global Coagulation Testing Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global coagulation testing market by product (instruments and consumables), technology (optical technology, mechanical technology, and electrochemical technology), application (activated clotting time, thrombin time, partial thromboplastin time, activated partial thromboplastin time, and prothrombin time), end user (hospitals, clinical laboratories, and point-of-care testing), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global coagulation testing market? Q.5 What are the business risks and threats to the global coagulation testing market? Q.6 What are emerging trends in this coagulation testing market and the reasons behind them? Q.7 What are some changing demands of customers in this coagulation testing market? Q.8 What are the new developments in this coagulation testing market? Which companies are leading these developments? Q.9 Who are the major players in this coagulation testing market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this coagulation testing market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global coagulation testing market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Instruments and Consumables), Technology (Optical Technology, Mechanical Technology, and Electrochemical Technology), Application (Activated Clotting Time, Thrombin Time, Partial Thromboplastin Time, Activated Partial Thromboplastin Time, and Prothrombin Time), and End User (Hospitals, Clinical Laboratories, and Point-of-Care Testing) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Coagulation Testing Market
4.1 Global Coagulation Testing Market by Region
4.2.1 Market by Product: Instruments and Consumables
4.2.2 Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.2.3 Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.2.4 Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.2.5 The United States Coagulation Testing Market
4.2.6 The Canadian Coagulation Testing Market
4.2.7 The Mexican Coagulation Testing Market
4.3.1 Market by Product: Instruments and Consumables
4.3.2 Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.3.3 Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.3.4 Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.3.5 The Coagulation Testing Market of United Kingdom
4.3.6 The Spanish Coagulation Testing Market
4.3.7 The German Coagulation Testing Market
4.3.8 The French Coagulation Testing Market
4.4.1 Market by Product: Instruments and Consumables
4.4.2 Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.4.3 Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.4.4 Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.4.5 The Chinese Coagulation Testing Market
4.4.6 The Indian Coagulation Testing Market
4.4.7 The Japanese Coagulation Testing Market
4.5.1 Market by Product: Instruments and Consumables
4.5.2 Market by Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology
4.5.3 Market by Application: Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (aPTT), and Prothrombin Time (PT)
4.5.4 Market by End User: Hospitals, Clinical Laboratories, and Point-Of-Care Testing
4.5.5 Brazilian Coagulation Testing Market
7.1.1 Growth Opportunities for the Global Coagulation Testing Market by Product
7.1.2 Growth Opportunities for the Global Coagulation Testing Market by Technology
7.1.3 Growth Opportunities for the Global Coagulation Testing Market by Application
7.1.4 Growth Opportunities for the Global Coagulation Testing Market by End User
7.1.5 Growth Opportunities for the Global Coagulation Testing Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
